Ma'aikata kantuna don EUR a Stock CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38-7/59774-06-0/1009- 14-9/705-60-2

Kamfaninmu yana mai da hankali kan gudanarwa, gabatar da ƙwararrun ma'aikata, da gina ginin ma'aikata, yana ƙoƙari sosai don haɓaka inganci da sanin alhaki na membobin ma'aikata.Kamfaninmu ya sami nasarar samun Takaddun shaida na IS9001 da Takaddar CE ta Turai na kantunan masana'anta don EUR a Stock CAS 1451-83-8 2-Bromo-3-Methylpophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38 -7/59774-06-0/1009-14-9/705-60-2, Muna ƙarfafa ku da ku kama kamar yadda muka dade muna son abokan hulɗa a cikin kasuwancinmu.Muna da tabbacin za ku gano yin kamfani tare da mu ba kawai mai amfani ba amma har ma da riba.Mun shirya don samar muku da abin da kuke buƙata.
Kamfaninmu yana mai da hankali kan gudanarwa, gabatar da ƙwararrun ma'aikata, da gina ginin ma'aikata, yana ƙoƙari sosai don haɓaka inganci da sanin alhaki na membobin ma'aikata.Kamfaninmu ya sami nasarar samun takardar shedar IS9001 da Takaddar CE ta TuraiChina 1451 83 8 da CAS 1451 83 8, A zamanin yau samfuranmu suna sayar da su a cikin gida da waje suna godiya ga goyon baya na yau da kullum da sababbin abokan ciniki.Muna samar da samfur mai inganci da farashi mai fa'ida, maraba da na yau da kullun da sabbin abokan ciniki suna ba mu hadin kai!

Ana amfani da 1-Bromo-2-methoxy-3-nitro-benzene azaman matsakaici na Eltrombopag.
Eltrombopag, wanda GlaxoSmithKline (GSK) ya haɓaka a Burtaniya kuma daga baya aka haɓaka tare da Novartis a Switzerland, shine farkon kuma kawai wanda aka amince da ƙananan ƙwayoyin cuta marasa peptide TPO agonist a duniya.An amince da Eltrombopag ta FDA ta Amurka a cikin 2008 don maganin cututtukan thrombocytopenic purpura (ITP), kuma a cikin 2014 don maganin anemia mai tsanani (AA).Hakanan shine magani na farko da FDA ta Amurka ta amince don maganin AA a cikin shekaru 30 na baya-bayan nan.
A cikin Disamba 2012, FDA ta Amurka ta amince da Eltrombopag don maganin thrombocytopenia a cikin marasa lafiya tare da ciwon hanta na kullum C (CHC), don haka marasa lafiya na hepatitis C tare da rashin jin dadi saboda ƙananan platelet zasu iya farawa da kuma kula da interferon bisa daidaitattun maganin cututtuka na hanta.A ranar 3 ga Fabrairu, 2014, GlaxoSmithKline ya sanar da cewa FDA ta ba da nasarar cancantar maganin miyagun ƙwayoyi na Eltrombopag don maganin hemopenia a cikin marasa lafiya tare da anemia mai tsanani na sinadarai (SAA) waɗanda ba su da cikakkiyar amsa ga immunotherapy.A ranar 24 ga Agusta, 2015, FDA ta Amurka ta amince da Eltrombopag don maganin thrombocytopenia a cikin manya da yara masu shekaru 1 da haihuwa tare da thrombocytopenia na rigakafi na yau da kullum (ITP) waɗanda basu da isasshen amsa ga corticosteroids, immunoglobulins ko splenectomy.A ranar 4 ga Janairu, 2018, an amince da Eltrombopag da za a jera shi a kasar Sin don maganin thrombocytopenia na rigakafi na farko (ITP).

Kamfaninmu yana mai da hankali kan gudanarwa, gabatar da ƙwararrun ma'aikata, da gina ginin ma'aikata, yana ƙoƙari sosai don haɓaka inganci da sanin alhaki na membobin ma'aikata.Kamfaninmu ya sami nasarar samun Takaddun shaida na IS9001 da Takaddar CE ta Turai na kantunan masana'anta don EUR a Stock CAS 1451-83-8 2-Bromo-3-Methylpophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38 -7/59774-06-0/1009-14-9/705-60-2, Muna ƙarfafa ku da ku kama kamar yadda muka dade muna son abokan hulɗa a cikin kasuwancinmu.Muna da tabbacin za ku gano yin kamfani tare da mu ba kawai mai amfani ba amma har ma da riba.Mun shirya don samar muku da abin da kuke buƙata.
factory Kantuna donChina 1451 83 8 da CAS 1451 83 8, A zamanin yau samfuranmu suna sayar da su a cikin gida da waje suna godiya ga goyon baya na yau da kullum da sababbin abokan ciniki.Muna samar da samfur mai inganci da farashi mai fa'ida, maraba da na yau da kullun da sabbin abokan ciniki suna ba mu hadin kai!